DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.112106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Alexandra H Mandarano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoimmune Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, Juvenile Diabetes Research Foundation International.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; St. Jude Graduate School of Biomedical Sciences, Memphis, TN 38105, USA.
- Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: maureen.mcgargill@stjude.org.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- Juvenile Diabetes Research Foundation International
- JDRF
- National Institutes of Health
- American Lebanese Syrian Associated Charities
- National Cancer Institute
Zitieren
APA
Mandarano, A. H., Harris, T. L., Creasy, B. M., Wehenkel, M., Duggar, M., Wilander, B. A., Mishra, A., Crawford, J. C., Mullen, S. A., Williams, K. M., Pillai, M., High, A. A., & McGargill, M. A. (2023). DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112106
Vancouver
Mandarano AH, Harris TL, Creasy BM, Wehenkel M, Duggar M, Wilander BA, et al. DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112106
BibTeX
@article{Mandarano2023,
author = {Mandarano, Alexandra H and Harris, Tarsha L and Creasy, Blaine M and Wehenkel, Marie and Duggar, Marygrace and Wilander, Benjamin A and Mishra, Ashutosh and Crawford, Jeremy Chase and Mullen, Sarah A and Williams, Katherine M and Pillai, Meenu and High, Anthony A and McGargill, Maureen A},
title = {DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.112106}
}
EUVIMED